期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
新型磷酸盐受体的合成与性能研究
1
作者 林旭聪 谢增鸿 +1 位作者 郭良洽 陈国南 《合成化学》 CAS CSCD 2003年第6期499-502,506,共5页
由二茂铁经甲酰基化、氧化和酰氯化制备的 1 ,1′ 二茂铁二酰氯与对苯二胺和对硝基苯胺缩合反应 ,合成了新型磷酸盐敏感试剂 :1 ,1′ 二 [(对苯二胺基 ) N 羰基 ] 二茂铁 (L1 )和 1 ,1′ 二 [(对硝基苯胺基 ) N 羰基 ]二茂铁 (L2 ) ,... 由二茂铁经甲酰基化、氧化和酰氯化制备的 1 ,1′ 二茂铁二酰氯与对苯二胺和对硝基苯胺缩合反应 ,合成了新型磷酸盐敏感试剂 :1 ,1′ 二 [(对苯二胺基 ) N 羰基 ] 二茂铁 (L1 )和 1 ,1′ 二 [(对硝基苯胺基 ) N 羰基 ]二茂铁 (L2 ) ,并研究了L1 ,L2与磷酸盐阴离子的电子结合性能。L1 ,L2对磷酸盐响应灵敏。L1对H2 PO-4响应的线性为 1 .0 0 μg/mL~ 1 0 .0 0 μg/mL ,检测限 (3σ/k)为 0 .0 1 μg/mL ;L2对PO3 -4响应的线性为 6.60 μg/mL~5 4.5 0 μg/mL ,检测限 (3σ/k)为 0 .0 3 μg/mL。 展开更多
关键词 磷酸盐受体 合成 二茂铁酰胺衍生物
下载PDF
鞘氨醇1-磷酸盐受体拮抗剂(FTY720)对咪喹莫特诱导的银屑病样小鼠模型皮肤中γδT细胞的作用研究 被引量:4
2
作者 覃慧 郑捷 《中华皮肤科杂志》 CAS CSCD 北大核心 2019年第6期395-400,共6页
目的研究鞘氨醇1-磷酸盐受体拮抗剂(FTY720)对银屑病样小鼠模型的治疗效应及分子机制。方法8只SPF级雌性C57BL/6小鼠,每只耳朵涂抹咪喹莫特10mg/d,连续涂7d。实验组3只于第2、4、6天腹腔注射FTY720,对照组5只注射磷酸盐缓冲液。每天测... 目的研究鞘氨醇1-磷酸盐受体拮抗剂(FTY720)对银屑病样小鼠模型的治疗效应及分子机制。方法8只SPF级雌性C57BL/6小鼠,每只耳朵涂抹咪喹莫特10mg/d,连续涂7d。实验组3只于第2、4、6天腹腔注射FTY720,对照组5只注射磷酸盐缓冲液。每天测量小鼠耳皮肤厚度,于第8天处死小鼠,观察耳皮肤组织学改变。取耳组织及颈部引流淋巴结细胞,流式细胞仪分析分泌白细胞介素(IL)17γδT细胞在两组小鼠皮肤及引流淋巴结组织中的比例变化,γδT细胞表面鞘氨醇1-磷酸盐受体KS1P1)及皮肤淋巴细胞抗原(CLA)表达情况。两独立样本均数比较采用t检验。结果咪座莫特涂抹2 d后,于第3天测量两组小鼠耳厚度,实验组小鼠耳厚度(0.217 mm ± 0.003 mm)低于对照组(0.232 μm ± 0.002 mm,t= 4.23,P < 0.01),直至用药7 d后,于第8天处死小鼠,实验组小鼠耳厚度均低于对照组(均P < 0.01)。耳皮肤组织病理显示,实验组小鼠耳组织表皮厚度(18.62 μm ±0.19 μm)低于对照组(27.79 μm± 1.58 μm,(= 4.35,P< 0.01);免疫荧光染色显示,实验组小鼠耳组织中性粒细胞浸润程度低于对照组。流式细胞仪检测耳组织显示,实验组中性粒细胞比例(1.57%±0.12%)低于对照组(3.03%±0.33%,t = 3.31,P= 0.016)。耳皮肤组织中,实验组γδT细胞、IL-17+γδT细胞比例(4.88%± 0.42%,40.53%± 1.76%)均低于对照组(9.45%± 1.22%.56.56%± 0.66%,t值分别为2.75、10.27, P < 0.05)。引流淋巴结中,实验组细胞、IL- 17γδT细胞比例亦高于对照组(t值分别为5.781、4.140,P< 0.05)。引流淋巴结中,实验组γδT细胞S1P1及CLA的荧光强度均低于对照组(P<0.05)。结论FTY720可通过下调γδT细胞S1P1及CLA的表达,使引流淋巴结中细胞的比例升高而降低其在皮肤中的比例,减少皮肤组织IL-17的产生,从而缓解由咪喹莫特诱导的小鼠银屑病。 展开更多
关键词 银屑病 小鼠 近交C57BL 受体 抗原 T细胞 γ-δ 白细胞介素17 鞘氨醇1-磷酸盐受体
原文传递
FTY720在多发性硬化治疗作用中的研究进展 被引量:2
3
作者 潘祺 李作孝 《西南军医》 2012年第1期95-96,共2页
多发性硬化(Muhipesclerosis,MS)是一种中枢神经系统自身免疫性疾病,激素等免疫抑制剂是其主要治疗方法。芬戈莫德(rrY720)是一种从冬虫夏草中分离出来的鞘氨醇1-磷酸盐受体抑制剂,具有促进淋巴细胞归巢、诱导淋巴细胞凋亡及免... 多发性硬化(Muhipesclerosis,MS)是一种中枢神经系统自身免疫性疾病,激素等免疫抑制剂是其主要治疗方法。芬戈莫德(rrY720)是一种从冬虫夏草中分离出来的鞘氨醇1-磷酸盐受体抑制剂,具有促进淋巴细胞归巢、诱导淋巴细胞凋亡及免疫耐受、抑制T淋巴细胞活性等作用,而发性硬化(MS)是一种中枢神经系统免疫性疾病,FTY720作为一种新型的免疫抑制剂治疗复发-缓解型MS,在二期临床试验和三期临床试验中显示着安全有效。 展开更多
关键词 FTY720 多发性硬化 鞘氨醇1-磷酸盐受体
下载PDF
TypeⅠinositol 1, 4, 5-triphosphate receptors increase in kidney of mice with fulminant hepatic failure 被引量:7
4
作者 Ying Wen Wei Cui Pei Liu 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第16期2344-2348,共5页
AIM: To delineate the mechanisms of renal vasoconstriction in hepatorenal syndrome (HRS), we investigated the expression of type I inositol 1, 4, 5-triphosphate receptors (IP3R I) of kidney in mice with fulminant... AIM: To delineate the mechanisms of renal vasoconstriction in hepatorenal syndrome (HRS), we investigated the expression of type I inositol 1, 4, 5-triphosphate receptors (IP3R I) of kidney in mice with fulminant hepatic failure (FHF). METHODS: FHF was induced by lipopolysaccharide (LPS) in D-galactosamine (GAIN) sensitized BALB/c mice. There were 20 mice in normal saline (NS)-treated group, 20 mice in LPS-treated group, 20 mice in GaIN- treated group, and 60 mice in GalN/LPS-treated group (FHF group). Liver and kidney tissues were obtained at 2, 6, and 9 h after administration. The liver and kidney specimens were stained with hematoxylin-eosin for studying morphological changes under light microscope. The expression of IP3R I in kidney tissue was tested by immunohistochemistry, Western blot and reverse transcription (RT)-PCR. RESULTS: Kidney tissues were morphologically normal at all time points in all groups. IP3R I proteins were found localized in the plasma region of glomerular mesangial cells (GMC) and vascular smooth muscle cells (VSMC) in kidney by immunohistochemical staining. In kidney of mice with FHF at 6 h and 9 h IP3R I staining was upregulated. Results from Western blot demonstrated consistent and significant increment of IP3R I expression in mice with FHF at 6 h and 9 h (t = 3.16, P 〈 0.05; t = 5.43, P 〈 0.01). Furthermore, we evaluated IP3R I mRNA expression by RT-PCR and observed marked upregulation of IP3R I mRNA in FHF samples at 2 h, 6 h and 9 h compared to controls (t = 2.97, P 〈 0.05; t = 4.42, P 〈 0.01; t = 3.81, P 〈 0.01). CONCLUSION: The expression of IP3R I protein increased in GMC and renal VSMC of mice with FHF, possibly caused by up-regulation of IP3R I mRNA. 展开更多
关键词 Hepatorenal syndrome Fulminant hepatic failure Type inositol 1 4 5-trisphophate receptors Glomerular mesangial cells Vascular smooth muscle cells
下载PDF
Sphingosine 1-phosphate acts as an activator for the porcine Gpr3 of constitutively active G protein-coupled receptors 被引量:2
5
作者 Bao-le ZHANG Ye LI +5 位作者 Jian-hua DING Fu-lu DONG Yan-jun HOU Bao-chun JIANG Fang-xiong SHI Yin-xue XU 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2012年第7期555-566,共12页
We cloned the complete coding sequences of porcine Gpr3, Gpr6, and Gpr12 genes. Further, on the basis of their high levels of sequence similarity, these genes are identified as a subfamily of G protein-coupled recepto... We cloned the complete coding sequences of porcine Gpr3, Gpr6, and Gpr12 genes. Further, on the basis of their high levels of sequence similarity, these genes are identified as a subfamily of G protein-coupled receptors. These putative protein sequences also showed high sequence identity with other mammalian orthologs, including several highly conserved motifs. A wide expression of the Gpr3 gene in pigs was observed through tissue distribution analysis by reverse transcriptase-polymerase chain reaction (RT-PCR) and real-time PCR, specially in the brain, pituitary, fat, liver and oocyte, where its strong expression was observed. The Gpr3 gene was found to be located on chromosome 6 and a single exon coded for the entire open reading frame. Expression of porcine Gpr3 in HEK293 cells resulted in constitutive activation of adenylate cyclase (AC) similar in amplitude to that produced by fully stimulated Gs coupled receptors. Moreover, sphingosine 1-phosphate (S1P) could increase AC activation via the constitutively active Gpr3 receptor. When a Gpr3-green fluorescent protein (GFP) construct was expressed in HEK293 cells, GFP-labeled Gpr3 protein was shown to be localized in the plasmalemma and subcellular membranes. After S1P treatment, agonist-mediated internalization could be visualized by confocal microscopy. In short, our findings suggest the porcine Gpr3, Gpr6, and Gpr12 genes as a subfamily of G protein-coupled receptors, and porcine Gpr3 was a constitutively active G protein-coupled receptor. Constitutive activation of AG and agonist-mediated internalization of Gpr3 receptor could be modulated by the S1 P, suggesting that S1P might act as an activator for porcine Gpr3 receptor. 展开更多
关键词 G protein-coupled receptor Constitutive activity Sphingosine 1-phosphate Receptor internalization Porcine Gpr3 Molecular cloning
原文传递
Advance in the Study of the Mechanisms Regulated by Sphingosine-1-Phosphate
6
作者 Fei Ye Xiangqian Kong Cheng Luo 《Science Foundation in China》 CAS 2010年第1期57-60,共4页
Sphingosine-1-phosphate(S1P) is a bioactive lipid messenger in the cells that regulate gene expression and NF-κB signal pathway through unknown mechanisms.Recently,Cheng Luo,associate professor of DDDC in Shanghai ... Sphingosine-1-phosphate(S1P) is a bioactive lipid messenger in the cells that regulate gene expression and NF-κB signal pathway through unknown mechanisms.Recently,Cheng Luo,associate professor of DDDC in Shanghai Institute of Materia Medica,whose project was funded by the National Natural Science Foundation of China,joined in a research team led by Professor Sarah Spiegel of Virginia Commonwealth University.The team continuously made significant breakthroughs in understanding the regulation mechanism of Sphingosine-1- Phosphate.In September 2009,in a paper published on SCIENCE magazine(Science 2009, 325:1254-7),they firstly demonstrated that S1P is a physiologically important regulator of histone deacetylases(HDACs),HDACs are direct intracellular targets of S1P.Furthermore,they identified the mechanism that S1P regulates gene expression through regulating the activity of HDACs.In June 24th,2010,in another paper to be published on NATURE magazine(Nature 2010,June 24th,advance online publication,(doi:10.1038/ nature09128)) which reports the regulation of NF-κB signaling pathway by S1P.They demonstrate that S1P is the missing cofactor for TRAF2(tumour-necrosis factor receptor-associated factor 2) and indicate a new paradigm for the regulation of lysine-63- linked poly-ubiquitination.The study also highlight the key role of SphK1 and its product S1P in TNF-αsignalling and the canonical NF-κB activation pathway, and then play crucial role in inflammatory,antiapoptotic and immune processes.The identification of new mechanisms fay which S1P regulates gene expression and TNF and NF-κB signaling pathway will light up the road to develop novel inhibitors that might be useful for treatment of cancer and in- flammatory diseases. 展开更多
关键词 SIP SphK1 SphK2 HDAC TRAF2 NF-kB signaling pathway
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部